Optometry360 Logo White
  • Conferences
  • Videos
  • Podcasts
  • Quizzes
  • About
    • About Us – Mission
    • Content Awards
    • Media Partners
    • Business Team
    • Brand Ambassadors
    • Industry Council
    • Advisory Board

What are you looking for?

  • Anterior Segment
  • Cataract
  • Cornea and External Disease
  • Diabetic Macular Edema
  • Dry Eye
  • Early Onset Cataracts
  • Exclusives
  • General
  • Geographic Atrophy
  • Glaucoma
  • Industry News
  • Inherited Retinal Disease
  • IOLs
  • Neurotrophic Keratitis
  • Ocular Surface Disease
  • Oculoplastics
  • Optometry
  • Pediatrics
  • Practice Management
  • Presbyopia
  • Refractive Surgery/Vision Correction
  • Residents & Young Ophthalmologists
  • Retina
  • Retina Care 360
  • Retinopathy of Prematurity
  • Spotlight Series
  • The Interventional Glaucoma Project
  • The Ophthalmic Project
  • Trending Topics
Spotlight - The Future of Cryopreserved Amniotic Membrane in Oculoplastic Surgery
Optometry360 Logo White
  • Conferences
  • Videos
  • Podcasts
  • Quizzes
  • About
    • About Us – Mission
    • Content Awards
    • Media Partners
    • Business Team
    • Brand Ambassadors
    • Industry Council
    • Advisory Board
Home > Industry News > Contralateral ocular occlusion reduces symptoms in negative dysphotopsia
  • Industry News

Contralateral ocular occlusion reduces symptoms in negative dysphotopsia

Ophthalmology 360
Contralateral ocular occlusion reduces symptoms in negative dysphotopsia

In a binocular visual field (VF) study of negative dysphotopsia (ND), the scotoma and symptoms were markedly reduced by partial or full contralateral ocular occlusion, suggesting that the central nervous system plays a role in ND, although the mechanism for this finding is uncertain, according to a study presented at AAO 2020 Virtual.

Negative dysphotopsia occurs in 15% to 20% of patients but no device, or “dysphotometer,” exists to measure the complaints; therefore, only patient-reported outcomes are used. The researchers analyzed the peripheral VF in patients with ND using Goldmann kinetic VF testing. Under the study, 23 patients with ND had VF testing under monocular contralateral occlusion with a partially opaque patch to measure the ND scotoma, or non-seeing area within the VF. Patients said that contralateral occlusion produced an improvement in ND symptoms. When testing was repeated with fully opaque occlusion, further improvement in symptoms was reported and documented. Binocular VF testing also was performed with partial contralateral occlusion using a peripherally opaque custom soft contact lens.

Results showed 78% of patients (20 cases) reported a mean 65% reduction of ND symptoms with contralateral occlusion. Under binocular VF testing, the ND scotoma was markedly larger than with partial occlusion of the fellow eye. However, these findings were not demonstrated with VF loss due to glaucoma or retinal detachment.

Reference
Masket S, et al. Central nervous system manifestations and modulation of negative dysphotopsia. Presented at: AAO 2020 Virtual [Session: PO007-20.]

Share

Related Content

  • Retina

Heidelberg receives FDA clearance for updated SPECTRALIS software

FDA approves Beovu label update to include safety information
  • Cataract

FDA approves first and only extended depth of focus IOL for cataract patients

  • Retina Care 360

Phase 3 SOL-1 trial results are a “landmark achievement” for investigational TKI therapy for wet AMD

  • Industry News

Topcon Healthcare partners with RemoniHealth on remote eye care

1 Min Read
  • Cornea and External Disease

DefEYE Inc launches as independent ophthalmic biologics company

  • Industry News

Harrow to acquire Melt Pharmaceuticals to expand non-opioid sedation options

Share

Editor's Picks

  • Neurotrophic Keratitis

Topical insulin shows real-world benefit in neurotrophic keratopathy

  • Retina

GLP-1 RAs have protective effects against AMD

  • Retina

Four-month injection intervals appear safe for long-term stable nAMD

Advisory Board

Saad Ahmad, MD

Ahmad A. Aref, MD, MBA

Roomasa Channa, MD

David Chow, MD, FRCS(C)

Sally L. Baxter, MD, MSc

Neel R. Desai, MD

Nadia Haqqie, MD

Simon Fung, MD, FRCOphth

Sumit Garg, MD

Ross Lakhanpal, MD, FACS

Sanjai Jalaj, MD

Anton Kolomeyer, MD, PhD

Shan Lin, MD

Steven R. Sarkisian, Jr., MD

See All
Optometry360 Logo

Ophthalmology 360® is a dynamic digital platform dedicated to advancing the field of eye care.

Get to Know Us

  • Home
  • About Us
  • Media Partners
  • Advertising Policy
  • Our Advisory Board

Sign up for our Newsletter

Sign up for our Newsletter to get our newest articles instantly!

  • Privacy Policy
  • Advertising Policy
  • Medical Disclaimer
IHM Logo

2026 Ophthalmology 360 is a trademark of International Healthcare Media, LLC. All rights reserved

  • MedJournal360 Icon
  • RareDisease360 Icon
  • MyHero360 Icon
  • Optometry360 Icon
  • Ophtalmology360 Icon